Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat critically ill patients with serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers.

Print   Email Essential Governance Documents View Audit Committee Charter     39.3 KB Compensation Committee Charter     37.3 KB Nominating and Corporate Governance Committee Charter     42.7 KB Code of Conduct and Ethics     46.7 KB Stock Option Grant Date Policy     21.4 KB = add file to Briefcase